| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/17/2013 | CN102159215B Treating various disorders using TrkB agonists |
| 07/17/2013 | CN102153606B Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof |
| 07/17/2013 | CN102106864B Application of icariin for preparing medicament for resisting myeloid-derived suppressor cells (MDSCs) |
| 07/17/2013 | CN102099047B Composition for controlling increase in blood glucose |
| 07/17/2013 | CN102093340B Preparation method and application of 2-methylindazole derivatives |
| 07/17/2013 | CN102083820B Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 07/17/2013 | CN102083434B Aqueous liquid containing gatifloxacin |
| 07/17/2013 | CN102076663B Piperidinyl derivative as modulator of chemokine receptor activity |
| 07/17/2013 | CN102076347B Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels |
| 07/17/2013 | CN102066345B Oxazolidine derivatives as NMDA antagonists |
| 07/17/2013 | CN102058679B Medicine or health-care food composition for treating atherosclerosis |
| 07/17/2013 | CN102056610B Fine granules having improved suspension performance in water |
| 07/17/2013 | CN102030771B Compound used as transient receptor potential vanilloid (TRPV1) blocker, medicinal composition and pharmaceutical application thereof |
| 07/17/2013 | CN102002052B Ginkgolides K and compound thereof as well as preparation method and use thereof |
| 07/17/2013 | CN101998951B Acylthiourea compound or salt thereof, and use thereof |
| 07/17/2013 | CN101951910B Pharmaceutical use of optimizing the treatment of proliferative diseases mediated by the tyrosine kinase receptor KIT with imatinib |
| 07/17/2013 | CN101939009B Pharmaceutical solid state forms |
| 07/17/2013 | CN101932577B Heteroaryl-substituted piperidines |
| 07/17/2013 | CN101910182B Antitumor agent |
| 07/17/2013 | CN101906122B Method for extracting rhoifolin and prepared medicament application thereof |
| 07/17/2013 | CN101903362B Tetrazole-substituted arylamide derivatives and their use as P2X3 and/or P2X2/3 purinergic receptor antagonists |
| 07/17/2013 | CN101879141B Taste-masking tilmicosin gastric-soluble particle preparation |
| 07/17/2013 | CN101878210B Amide compounds as boosters of antivirals |
| 07/17/2013 | CN101835501B Composition for treatment of joint disease |
| 07/17/2013 | CN101821253B Piperidine derivative |
| 07/17/2013 | CN101784548B Purine derivatives and their use as modulators of Toll-like receptor 7 |
| 07/17/2013 | CN101784258B Method of producing microparticles to be ingested into the body, microparticles to be ingested into the body and dispersion and medicinal composition containing the same |
| 07/17/2013 | CN101744978B Drug composition for preventing and curing diabetes mellitus |
| 07/17/2013 | CN101743246B 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents |
| 07/17/2013 | CN101743240B ((Phenyl)imidazolyl)methylheteroaryl compounds |
| 07/17/2013 | CN101742986B Stable formulation of amorphous perindopril salts, a process for the preparation thereof on industrial scale and use thereof in the treatment of hypertension |
| 07/17/2013 | CN101677947B Pharmaceutical formulation comprising an insulin derivative |
| 07/17/2013 | CN101663270B Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| 07/17/2013 | CN101641339B Compounds for the prevention and treatment of cardiovascular diseases |
| 07/17/2013 | CN101622242B Bicyclic derivatives as CETP inhibitors |
| 07/17/2013 | CN101619056B Benzothiophene alkanol piperazine derivatives and use thereof as antidepressant medicaments |
| 07/17/2013 | CN101583271B Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 07/17/2013 | CN101578279B Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors |
| 07/17/2013 | CN101553489B 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, methods for their preparation and their use as antiviral agents |
| 07/17/2013 | CN101541752B 抗菌的喹啉衍生物 Antibacterial quinoline derivatives |
| 07/17/2013 | CN101534831B Tyrosine inhibitors containing a zinc binding moiety |
| 07/17/2013 | CN101528695B Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 07/17/2013 | CN101528225B 2-aminobenzoxazole carboxamides as 5HT3 modulators |
| 07/17/2013 | CN101490036B Factor xa inhibitors |
| 07/17/2013 | CN101485650B Diclofenac sodium and lidocaine hydrochloride injection and preparation method thereof |
| 07/17/2013 | CN101479008B Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower HDL-C and lower cholesterol |
| 07/17/2013 | CN101460168B Benzoimidazol-2-yl pyridines as modulators of the histamine h4 receptor |
| 07/17/2013 | CN101454310B Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/17/2013 | CN101448943B RNAi-mediated inhibition of tumor necrosis factor alpha-related conditions |
| 07/17/2013 | CN101443019B Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine |
| 07/17/2013 | CN101420966B Use of non-digestable sacharides for giving an infant the best start after birth |
| 07/17/2013 | CN101420955B Dihydrodiazepines useful as inhibitors of protein kinases |
| 07/17/2013 | CN101415683B New compounds |
| 07/17/2013 | CN101412744B Anti-angiogenic compositions and methods of use thereof |
| 07/17/2013 | CN101405054B Compositions and methods for preserving brain function |
| 07/17/2013 | CN101397564B Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/17/2013 | CN101378765B Hydrophobic elastomeric polymer chemical method for inhibiting the growth of onychomycosis and urushiol-induced allergic contact dermatitis |
| 07/17/2013 | CN101378746B Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| 07/17/2013 | CN101378667B High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith |
| 07/17/2013 | CN101374815B Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (HIF) |
| 07/17/2013 | CN101374571B Na/K-ATPase ligand |
| 07/17/2013 | CN101360999B Intraocular pressure-regulated early genes and uses thereof |
| 07/17/2013 | CN101312711B Pharmaceutical composition free from dexpanthenol, calcium ions, and phosphate, and use of calcium chelating agent and ophthalmologically compatible viscosity regulator |
| 07/17/2013 | CN101312661B Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses |
| 07/17/2013 | CN101304726B Cosmetic and pharmaceutical compositions comprising lauroyl proline and an ester of anhydrohexitol and of an aliphatic carboxylic acid |
| 07/17/2013 | CN101248050B Organic compounds |
| 07/17/2013 | CN101222926B Methods and compositions for treating or preventing cancer |
| 07/17/2013 | CN101212979B 内脏脂肪蓄积抑制剂 Visceral fat accumulation inhibitor |
| 07/17/2013 | CN101160123B Combinations of therapeutic agents |
| 07/17/2013 | CN101087593B Colonic purgative composition with soluble binding agent |
| 07/17/2013 | CN101006063B Five-membered heterocycles useful as serine protease inhibitors. |
| 07/16/2013 | US8487132 Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of depression disorders, their preparation processes and uses thereof |
| 07/16/2013 | US8487131 Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2) |
| 07/16/2013 | US8487130 Menthylcarboxamides and their use as cooling agents |
| 07/16/2013 | US8487121 Chromane derivatives as TRPV3 modulators |
| 07/16/2013 | US8487117 Atropisomers of (hydroxyalkyl) pyrrole derivatives |
| 07/16/2013 | US8487111 Substituted oxazolidinones and their use |
| 07/16/2013 | US8487110 Method for preparing isofagomine and its derivatives |
| 07/16/2013 | US8487107 Biphenyl compounds useful as muscarinic receptor antagonists |
| 07/16/2013 | US8487100 Compounds for binding to ER alpha/beta and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof |
| 07/16/2013 | US8487099 Gamma secretase modulators |
| 07/16/2013 | US8487097 Reference standard for characterization of rosuvastatin |
| 07/16/2013 | US8487096 Imidazo[1,2-B][1,2,4]triazines as C-MET inhibitors |
| 07/16/2013 | US8487093 β-lactamase inhibitors |
| 07/16/2013 | US8487090 Water solution of 20(R)-ginsenoside Rg3 pharmaceutical composition and process thereof |
| 07/16/2013 | US8487009 1,2-diphenylethene derivatives for treatment of immune diseases |
| 07/16/2013 | US8487008 Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors |
| 07/16/2013 | US8487007 Pharmaceutical formulation containing palmitoyl ethanolamide and stearoyl ethanolamide |
| 07/16/2013 | US8487006 Method of enhancing TGF-β signalling |
| 07/16/2013 | US8487005 Tranexamic acid formulations |
| 07/16/2013 | US8487004 Local treatment of neurofibromas |
| 07/16/2013 | US8487003 Treatment of cancer by administration of perfluorooctanoic acid |
| 07/16/2013 | US8487002 Controlled-release compositions |
| 07/16/2013 | US8487001 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 07/16/2013 | US8487000 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 07/16/2013 | US8486999 Long-chain oxyaminopolyol based gelator and gel |
| 07/16/2013 | US8486998 Compositions for prevention/prophylactic treatment of poison ivy dermatitis |
| 07/16/2013 | US8486997 External preparation for skin |
| 07/16/2013 | US8486996 Aroylfuranes and aroylthiophenes |
| 07/16/2013 | US8486995 Acaricidal active substance combinations |